Leaderboard

Fr | De
Feedback | Impressum | Sitemap
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Voies biliaires » Néoplasie 29. Août 2025
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Cholécystite - Cholélithiase
Néoplasie
Autres
Foie
Estomac / intestins
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 819  Page précédente Page suivante
   
   Articles 1 - 20 / 16378  
   
Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma.
In Vivo
Aydemir E, Yilmaz F, Türkel A, Ate, Do.
PMID: 40877181 [PubMed - indexed for MEDLINE]

A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy.
Anticancer Res
Kim JH, Yoo C, Jeong H, Cheon J, Kim KP, Ryoo BY, Chang HM, Oh CR, Ryu HW, Park I.
PMID: 40877003 [PubMed - indexed for MEDLINE]

Primary Intrahepatic Biliary Neuroendocrine Neoplasms: A Case Report and Literature Review.
J Gastrointest Cancer
Chen Z, Hu L, Guo Z, Chu J, He T, E C, Jiang T.
PMID: 40875127 [PubMed - indexed for MEDLINE]

Contrast-enhanced ultrasound for diagnosing subtypes of intrahepatic cholangiocarcinoma: a comparative study with poorly differentiated hepatocellular carcinoma.
Cancer Imaging
Zhang N, Yang Y, Lin K, Qiao B, Yang DP, Jin DD, Li B, Zhao DL, Xie XH, Xie XY, Kang JH, Zhuang BW.
PMID: 40866908 [PubMed - indexed for MEDLINE]

Cholecystitis and cholangiocarcinoma: a two-sample Mendelian randomization study.
BMC Gastroenterol
Gao X, Gao H, Wang S, Tang F, Zhao Y, Li Y.
PMID: 40859233 [PubMed - indexed for MEDLINE]

Integrating multi-omics in bile for biomarker discovery in cholangiocarcinoma.
Hepatol Commun
Xia JY, Komanduri S, Keswani RN, Rodrigues TR, Sinha J, Rengarajan A, Tran P, Hepler C, Prindle A, Aadam AA.
PMID: 40857390 [PubMed - indexed for MEDLINE]

Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis.
Liver Int
Altenmüller J, Wiegard C, Sebode M, Lohse AW, Villard C, Kechagias S, Nilsson E, Rorsman F, Marschall HU, Jokelainen K, Bergquist A, Färkkilä M, Schramm C.
PMID: 40856347 [PubMed - indexed for MEDLINE]

Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.
Liver Int
Niger M, Rimini M, Castet F, Melzer A, Rizzato MD, Pressiani T, Lavacchi D, Aprile G, Angela T, Saladino T, Silvia N, Cito P, Pastorino A, Terán-Brage E, Sciortino C, Camera S, Pircher C, Persano M, Mazzaferro V, Foti S, Vega KS, Ettrich TJ, Antonuzzo L, Rimassa L, Lonardi S, Perkhofer L, Macarulla T, Pietrantonio F, Casadei-Gardini A.
PMID: 40856270 [PubMed - indexed for MEDLINE]

Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies.
Front Immunol
Xue J, Zhang L, Zhang K, Zhou K, Zhao H.
PMID: 40861435 [PubMed - indexed for MEDLINE]

A Medical Anthropology Assessment of Community Liver Cancer Risks: Qualitative Comparisons of Communities with Different Risk Profiles in Thailand.
Asian Pac J Cancer Prev
Loffredo CA, Navasumrit P, Pupacdi B, Rabibhadana S, Phornphutkul K, Harris C, Wang XW, Ruchirawat M, Wang JH.
PMID: 40849700 [PubMed - indexed for MEDLINE]

The Ideal Second-Line Treatment Options for Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine-Based First-Line Chemotherapy: A Result From Bayesian Network-Meta Analysis.
Asian Pac J Cancer Prev
Syarifuddin E, Aryanti C.
PMID: 40849693 [PubMed - indexed for MEDLINE]

First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study.
Signal Transduct Target Ther
Shi G, Huang X, Ma L, Li H, Zhong J, Wang J, Gao Q, Guo X, Qiu S, Sun H, Shi Y, Huang X, Wang X, Yi Y, Zhu X, Huang C, Ding Z, Chen Y, He Y, Shen Y, Sun Q, Zhou J, Fan J.
PMID: 40835595 [PubMed - indexed for MEDLINE]

Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial.
BMC Cancer
Yang X, Dai YH, Peng H, Zhang MS, Fu Q, Liu SF, Sun L, Zou YM, Xu HS, Qiu P, Qiu H, Huang Q, Cheng HH, Zhuang L.
PMID: 40819029 [PubMed - indexed for MEDLINE]

A single-center retrospective cohort study on the efficacy and safety of temporary endoscopic nasobiliary drainage in patients with unresectable malignant biliary obstruction with endoscopic biliary stent.
BMC Surg
Liu H, Shi C, Yan Z.
PMID: 40814049 [PubMed - indexed for MEDLINE]

Monitoring miR-29a for targeted therapy of cholangiocarcinoma based on a photoelectric sensor.
Mikrochim Acta
Hao W, Chen C, Cao F, Xu M, Zheng J.
PMID: 40810868 [PubMed - indexed for MEDLINE]

Real-world efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient biliary tract cancer: An AGEO study.
Eur J Cancer
Campo-Le-Brun I, Grapinet E, Aurillac V, Hollebecque A, Parent P, Girot P, Tougeron D, Gendreau M, Chanez B, Assenat E, Pernot S, Alouani E, Taieb J, Javed S, Touchefeu Y, Roth G, Muller M, Bachet JB, Lequoy M, Hautefeuille V, Ben-Abdelghani M, Masson T, Guimbaud R, Boilève A, Decraecker M.
PMID: 40795523 [PubMed - indexed for MEDLINE]

Comparative analysis of differences for pathological upgrade and incomplete resection in endoscopic snare papillectomy for ampullary adenomas: A single-institution retrospective study.
PLoS One
Chen X, Huang J, Chen X, Luo Q, Gao M, Wu J, He X.
PMID: 40794694 [PubMed - indexed for MEDLINE]

Predicting clinical benefit response after neoadjuvant chemotherapy in locally advanced gallbladder cancer: retrospective analysis.
BJS Open
Patkar S, Gundavda K, Polusany K, Yelamanchi R, Varty GP, Shah N, Pawar A, Ostwal V, Ramaswamy A, Bhargava P, Goel M.
PMID: 40794563 [PubMed - indexed for MEDLINE]

Preoperative combined biomarker model of fibrinogen-to-albumin ratio and systemic immune-inflammation index to carbohydrate antigen 19-9 ratio predicts survival in distal cholangiocarcinoma after pancreatoduodenectomy: a retrospective cohort study.
BMC Surg
Wang F, He Q, Lyu S.
PMID: 40790572 [PubMed - indexed for MEDLINE]

Serum peptide biomarkers by MALDI-TOF MS coupled with machine learning for diagnosis and classification of hepato-pancreato-biliary cancers.
Sci Rep
Prajumwongs P, Titapun A, Thanasukarn V, Jareanrat A, Khuntikeo N, Rattanarak K, Namwat N, Klanrit P, Wangwiwatsin A, Chindaprasirt J, Koonmee S, Sa-Ngiamwibool P, Muangritdech N, Charoenlappanit S, Jaresitthikunchai J, Roytrakul S, Loilome W.
PMID: 40783440 [PubMed - indexed for MEDLINE]

   
   Articles 1 - 20 / 16378    Page 1 de 819  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 
  Intervalle de temps demandé  
   

Sky right 1
Mediscope AG  E-mail: info@mediscope.ch 
Disclaimer | Privacy Policy | Publicité